Skip to main content
Search
section
Global
News
Careers
Language & Country Selector for Desktop
Ireland
|
en
Choose Location
Americas
Asia Pacific
Europe
International
Middle East & Africa
Argentina |
es
Brazil |
pt
Canada |
fr
Canada |
en
Central America |
es
Colombia |
es
Mexico |
es
United States |
en
Venezuela |
vs
Australia |
en
Bangladesh |
en
Hong Kong S.A.R. |
zh
India |
en
Indonesia |
en
Japan |
ja
Korea |
ko
Mainland China |
zh
Malaysia |
en
Pakistan |
en
Philippines |
en
Singapore |
en
Taiwan |
zh
Austria |
de
Belgium |
nl
Belgium |
fr
Bulgaria |
bg
Czech Republic |
en
Czech Republic |
cs
Denmark |
da
Estonia |
et
Finland |
fi
France |
fr
Germany |
de
Greece |
el
Hungary |
hu
Ireland |
en
Italy |
it
Latvia |
lv
Lithuania |
lt
Netherlands |
nl
Norway |
no
Poland |
pl
Portugal |
pt
Romania |
ro
Russia |
ru
Serbia |
sr
Slovakia |
sk
Spain |
es
Sweden |
sv
Switzerland |
fr
Switzerland |
de
United Kingdom |
en
Global |
en
Novartis Foundation |
en
Sandoz |
en
Egypt |
en
Israel |
he
South Africa |
en
Turkey |
tr
Language & Country Selector for Mobile
Ireland
Choose Location
europe
Americas
Asia Pacific
Europe
International
Middle East & Africa
Argentina |
es
Australia |
en
Austria |
de
Bangladesh |
en
Belgium |
nl
Belgium |
fr
Brazil |
pt
Bulgaria |
bg
Canada |
fr
Canada |
en
Central America |
es
Colombia |
es
Czech Republic |
en
Czech Republic |
cs
Denmark |
da
Egypt |
en
Estonia |
et
Finland |
fi
France |
fr
Germany |
de
Global |
en
Greece |
el
Hong Kong S.A.R. |
zh
Hungary |
hu
India |
en
Indonesia |
en
Ireland |
en
Israel |
he
Italy |
it
Japan |
ja
Korea |
ko
Latvia |
lv
Lithuania |
lt
Mainland China |
zh
Malaysia |
en
Mexico |
es
Netherlands |
nl
Norway |
no
Novartis Foundation |
en
Pakistan |
en
Philippines |
en
Poland |
pl
Portugal |
pt
Romania |
ro
Russia |
ru
Sandoz |
en
Serbia |
sr
Singapore |
en
Slovakia |
sk
South Africa |
en
Spain |
es
Sweden |
sv
Switzerland |
fr
Switzerland |
de
Taiwan |
zh
Turkey |
tr
United Kingdom |
en
United States |
en
Venezuela |
vs
Menu
About
Novartis in Ireland
Strategy
Country Leadership Team
Contact
About
Patients and Caregivers
Novartis Commitment to Patients and Caregivers
Education and Awareness
Patient Resources
Adverse Event Reporting
Novartis Societal Impact
Patients and Caregivers
Healthcare Professionals
Healthcare professional country resource
Adverse Event Reporting
Novartis Clinical Trials
Healthcare Professionals
ESG
Ethical Behavior
Code of Ethics
SpeakUp
Ethics, Risk and Compliance
Environmental Sustainability
ESG
News
News Archive
Stories
Contacts
News
Careers
Career Search
Working in Novartis Ireland
Learning and Development
Early Talent
How We Work
Well-being
Diversity & Inclusion
Awards and Recognition
Careers
Coronavirus
Coronavirus
Home
Education & Awareness
Story Navigation
All Topics
Education & Awareness
Corporate
People and Culture
icon
List View
Education & Awareness
Heart of Our City initiative improves health for D8 residents
Education & Awareness
What do you know about AMD?
Education & Awareness
Novartis LIGHTS UP for Rare Disease Day 2021
Education & Awareness
Novartis launches new campaign with RTÉ’s Evanne Ni Chuilinn calling on migraine sufferers to #TameYourMigraine
Education & Awareness
Majority of Migraine Sufferers Report Experiencing More Frequent and Severe Migraines During Pandemic
Education & Awareness
MS Ireland and Novartis launch video series to support the wellbeing of those living with multiple sclerosis (MS) during Covid-19 pandemic
Education & Awareness
‘We’ll See You’ Campaign - Urges Irish Public to Keep Eye Care Appointments and Be Vigilant for Signs of Age-Related Macular Degeneration
Education & Awareness
Novartis Ireland Supports The Saoirse Foundation’s BUMBLEance
Education & Awareness
Introducing the Immune Thrombocytopenia (ITP) Pocket Log
Education & Awareness
Visionary: Silke Mader has a vision for the care of premature infants and their parents
Education & Awareness
MS Explored - An Informational Meeting for Young People Living with Multiple Sclerosis in Ireland
Education & Awareness
4th annual European Patient Innovation Summit #EPIS
Pagination
1
2
3
4
›
Next page
